Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sartorius AG's Enterprise Value is $21,577 Mil.
Sartorius AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $589 Mil. Therefore, Sartorius AG's EV-to-EBIT ratio for today is 36.62.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sartorius AG's Enterprise Value is $21,577 Mil.
Sartorius AG's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $1,082 Mil. Therefore, Sartorius AG's EV-to-EBITDA ratio for today is 19.95.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sartorius AG's Enterprise Value is $21,577 Mil.
Sartorius AG's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $4,135 Mil. Therefore, Sartorius AG's EV-to-Revenue ratio for today is 5.22.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Sartorius AG's Enterprise Value is $21,577 Mil.
Sartorius AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $516 Mil. Therefore, Sartorius AG's EV-to-FCF ratio for today is 41.78.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Sartorius AG (OTCPK:SUVPF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sartorius AG's current Enterprise Value is $21,577 Mil.
Sartorius AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $589 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sartorius AG's current Enterprise Value is $21,577 Mil.
Sartorius AG's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,082 Mil.
Sartorius AG's current Enterprise Value is $21,577 Mil.
Sartorius AG's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,135 Mil.
Sartorius AG's current Enterprise Value is $21,577 Mil.
Sartorius AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,033 Mil.
Sartorius AG's current Enterprise Value is $21,577 Mil.
Sartorius AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $516 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sartorius AG Enterprise Value Related Terms
Sartorius AG Enterprise Value Historical Data
* Premium members only.
The historical data trend for Sartorius AG's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SUVPF vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, Sartorius AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sartorius AG Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sartorius AG's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sartorius AG's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sartorius AG (SUVPF) has a Enterprise Value of $21,577 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sartorius AG and its competitors.
Is Sartorius AG's Enterprise Value too high?
Sartorius AG's current Enterprise Value is $21,577 Mil. Overall, Sartorius AG has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's Enterprise Value compare to ISRG and BDX?
Sartorius AG's Enterprise Value of $21,577 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sartorius AG and its competitors. Sartorius AG's current Enterprise Value is $21,577 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Based on GuruFocus' analysis, Sartorius AG (SUVPF) is currently considered Modestly Undervalued. The stock's GF Value™ is $268.44, compared to a current price of $243.82 — trading 9.2% below its estimated fair value. The current Enterprise Value is $21,577 Mil. Sartorius AG's overall GF Score™ is 85/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Sartorius AG (SUVPF), the current Enterprise Value is $21,577 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sartorius AG (SUVPF) Overvalued in 2026?
Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued.
The current stock price of $243.82 is trading 9.2% below its estimated GF Value™ of $268.44.
GuruFocus considers Sartorius AG to be Modestly Undervalued.
Key valuation signals for SUVPF:
Enterprise Value: $21,577 Mil
GF Value™: $268.44 vs. price of $243.82 (9.2% below fair value)
No single metric tells the full story. See the SUVPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
85GF Score
Get the complete analysis for SUVPF
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SUVPF has been successfully added to your 
